Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Salvato

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Waste Management (New York, N.Y.)|October 16, 2025
Potential role of Galleria mellonella larval microbiota in polyethylene biodegradationAndressa F Pivato, Gabriela M Miranda, Janira Prichula, et al.
Journal of Virology|February 1, 2005
The proline-rich homeodomain (PRH/HEX) protein is down-regulated in liver during infection with lymphocytic choriomeningitis virusMahmoud Djavani, Ivan Topisirovic, Juan Carlos Zapata, et al.
Vaccine|March 16, 2007
A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunityRicardo Carrion, Jean L Patterson, Curtis Johnson, et al.
Plos Neglected Tropical Diseases|September 27, 2013
Transcriptome analysis of human peripheral blood mononuclear cells exposed to Lassa virus and to the attenuated Mopeia/Lassa reassortant 29 (ML29), a vaccine candidateJuan Carlos Zapata, Ricardo Carrion, Jean L Patterson, et al.
Virology|January 18, 2006
A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteinsPeter J Bredenbeek, Richard Molenkamp, Willy J M Spaan, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1996
Utility of SHIV for testing HIV-1 vaccine candidates in macaquesY Lu, M S Salvato, C D Pauza, et al.
Journal of Virology|December 17, 2013
Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidateJuan C Zapata, Marco Goicochea, Yuka Nadai, et al.
Journal of Virology|May 25, 2007
Early blood profiles of virus infection in a monkey model for Lassa feverMahmoud M Djavani, Oswald R Crasta, Juan Carlos Zapata, et al.
Virology Journal|February 14, 2013
An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunityJuan C Zapata, Bhawna Poonia, Joseph Bryant, et al.
Vaccine|August 12, 2008
Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primatesIgor S Lukashevich, Ricardo Carrion, Maria S Salvato, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Waste Management (New York, N.Y.)|October 16, 2025
Potential role of Galleria mellonella larval microbiota in polyethylene biodegradationAndressa F Pivato, Gabriela M Miranda, Janira Prichula, et al.
Journal of Virology|February 1, 2005
The proline-rich homeodomain (PRH/HEX) protein is down-regulated in liver during infection with lymphocytic choriomeningitis virusMahmoud Djavani, Ivan Topisirovic, Juan Carlos Zapata, et al.
Vaccine|March 16, 2007
A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunityRicardo Carrion, Jean L Patterson, Curtis Johnson, et al.
Plos Neglected Tropical Diseases|September 27, 2013
Transcriptome analysis of human peripheral blood mononuclear cells exposed to Lassa virus and to the attenuated Mopeia/Lassa reassortant 29 (ML29), a vaccine candidateJuan Carlos Zapata, Ricardo Carrion, Jean L Patterson, et al.
Virology|January 18, 2006
A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteinsPeter J Bredenbeek, Richard Molenkamp, Willy J M Spaan, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1996
Utility of SHIV for testing HIV-1 vaccine candidates in macaquesY Lu, M S Salvato, C D Pauza, et al.
Journal of Virology|December 17, 2013
Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidateJuan C Zapata, Marco Goicochea, Yuka Nadai, et al.
Journal of Virology|May 25, 2007
Early blood profiles of virus infection in a monkey model for Lassa feverMahmoud M Djavani, Oswald R Crasta, Juan Carlos Zapata, et al.
Virology Journal|February 14, 2013
An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunityJuan C Zapata, Bhawna Poonia, Joseph Bryant, et al.
Vaccine|August 12, 2008
Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primatesIgor S Lukashevich, Ricardo Carrion, Maria S Salvato, et al.
Pageof 10